Rational and computation-assisted engineering of a compact and efficient StaCas9 genome editor
Li, M.; You, W.; Tian, Y.; Liu, J.; Wang, S.; Lin, J.; Wang, Y.
Show abstract
Type II-A CRISPR-Cas9 nucleases are widely used for genome editing, yet their functional diversity and therapeutic potential remain incompletely explored. In this study, we systematically analyzed natural variation in PAM recognition among SaCas9 orthologs and identified StaCas9 as a compact and efficient nuclease recognizing an NNG PAM. Structural and sequence analyses revealed that S983 within the PAM-interacting domain contributes to the PAM preference of StaCas9. StaCas9 enabled efficient genome editing across multiple endogenous loci in human cells and achieved high-efficiency disruption of the therapeutically relevant PCSK9 gene, supporting its potential for gene therapy. Furthermore, guided by structural insights, we significantly enhanced the editing activity of StaCas9. Together, these results expand our understanding of PAM recognition in type II-A Cas9 nucleases and establish StaCas9 as a high-performance genome-editing tool for therapeutic applications.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Engineered minimal type I CRISPR-Cas system for transcriptional activation and base editing in human cells 97%
- Chemically-inducible CRISPR/Cas9 circuits for ultra-high dynamic range gene perturbation 97%
- Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing 97%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.